Toggle Navigation

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Published:
May. 2010
Type:
Staff Publication
Topic:
Postpartum Hemorrhage
Authors:
Blum, Jennifer, Winikoff, Beverly Widmer, M., Blum, J., Hofmeyr, G.J., Carroli, G., Abdel-Aleem, H., Lumbiganon, P., Ngoc, N.T.N., Wojdyla, D., Thinkhamrop, J., Singata, M., Mignini, L.E., Abdel-Aleem, M.A., Thach, T.S., Winikoff, B.

PDF

Not all resources are available in all formats. Select language to check availability.

This article reports on a study evaluating misoprostol used in conjunction with routine injectable uterotonics for treatment of postpartum hemorrhage. The findings do not support clinical use of 600mcg sublingual misoprostol in addition to standard injectable uterotonics for treatment of postpartum hemorrhage.

Access the abstract.

View All Resources